gm-csf
Showing 26 - 50 of 81
Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)
Recruiting
- Relapsed Solid Tumor
- Refractory Solid Tumor
- Abemaciclib
- +4 more
-
Phoenix, Arizona
- +28 more
Dec 7, 2022
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
Multiple Myeloma Trial in United States (procedure, drug, biological)
Completed
- Multiple Myeloma
- Tumor Cell Collection
- +6 more
-
San Francisco, California
- +14 more
Jul 11, 2022
Malignant Melanoma Trial in Oslo (Ipilimumab, UV1 vaccine, GM-CSF)
Active, not recruiting
- Malignant Melanoma
- Ipilimumab
- +2 more
-
Oslo, NorwayOslo University Hospital, Radiumhospitalet
May 14, 2021
Metastatic Cancer Trial in Scottsdale (Keytruda Injectable Product, Yervoy Injectable Product, GM-CSF)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +3 more
-
Scottsdale, ArizonaVincere Cancer Center
Feb 8, 2021
Advanced Malignant Solid Tumor Trial in Hangzhou (biological, other, drug, procedure)
Recruiting
- Advanced Malignant Solid Tumor
- iNeo-Vac-P01
- +3 more
-
Hangzhou, Zhejiang, ChinaRun Run Shaw Hospital Affiliated to Zhejiang University School o
Apr 25, 2021
Melanoma Trial in Rochester (GM-CSF, Standard of Care)
Completed
- Melanoma
- GM-CSF
- Standard of Care
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 29, 2020
Arthritis, Rheumatoid Trial in Cambridge (drug, biological, other)
Terminated
- Arthritis, Rheumatoid
- Placebo
- +4 more
-
Cambridge, United KingdomGSK Investigational Site
Nov 6, 2020
Breast Cancer Trial in United States (Herceptin, NeuVax vaccine, GM-CSF)
NSCLC Stage IV Trial in Shanghai (GM-CSF, Sintilimab, SBRT)
Recruiting
- NSCLC Stage IV
- GM-CSF
- +2 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 25, 2019
Thin Endometrium Trial in Hangzhou (GM-CSF, 17-ß estradiol)
Unknown status
- Thin Endometrium
- GM-CSF
- 17-ß estradiol
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital
Sep 20, 2019
Ewing's Sarcoma, Rhabdomyosarcoma Trial run by the NCI (EF-1 Peptide, EF-2 Peptide, PXFK Peptide)
Completed
- Ewing's Sarcoma
- Rhabdomyosarcoma
- EF-1 Peptide
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 27, 2019
Lymphoma, Leukemia, Transplantation, Stem Cell Trial in Houston (GM-CSF, Rituximab, NK Cell Infusion)
Completed
- Lymphoma
- +4 more
- GM-CSF
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 29, 2019
Breast Cancer Trial in Orange (Doxorubicin, Cyclophosphamide, Carboplatin)
Completed
- Breast Cancer
- Doxorubicin
- +6 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Feb 13, 2019
Colon Cancer, Rectal Cancer Trial in Orange (GM-CSF)
Completed
- Colon Cancer
- Rectal Cancer
- GM-CSF
-
Orange, CaliforniaChao Family Comprehensive Cancer Center
Feb 6, 2018
Leukemia Trial in Houston (Peptide Vaccine (PR1 Peptide), Peginterferon alfa-2b, Imatinib)
Terminated
- Leukemia
- Peptide Vaccine (PR1 Peptide)
- +3 more
-
Houston, TexasUT MD . Anderson Cancer Center
Jul 23, 2018
Melanoma, Cancer of Skin Trial (Reolysin, GM-CSF)
Withdrawn
- Melanoma
- Cancer of Skin
- Reolysin
- GM-CSF
- (no location specified)
May 1, 2018
Kidney Cancer Trial in Charleston (PEG-interferon alfa-2b, GM-CSF, thalidomide)
Terminated
- Kidney Cancer
- PEG-interferon alfa-2b
- +2 more
-
Charleston, South CarolinaHollings Cancer Center at Medical University of South Carolina
Jun 13, 2018
Non-Hodgkin's Lymphoma, Hodgkin's Disease, Multiple Myeloma Trial in Lebanon (GM-CSF, IL-2)
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- GM-CSF
- IL-2
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Apr 23, 2018
Prostate Cancer Metastatic Trial in Worldwide (biological, drug, other)
Completed
- Prostate Cancer Metastatic
- PROSTVAC-V
- +4 more
-
Anchorage, Alaska
- +219 more
Aug 22, 2019
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020
Metastatic Colorectal Cancer Trial in Fuzhou (Irinotecan, Oxaliplatin, Levoleucovorin)
Withdrawn
- Metastatic Colorectal Cancer
- Irinotecan
- +5 more
-
Fuzhou, Fujian, ChinaRongbo Lin
Mar 23, 2018
Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Diffuse Trial in Boston (GM-CSF, CHOP, Rituximab)
Terminated
- Lymphoma, Non-Hodgkin
- +2 more
- GM-CSF
- +2 more
-
Boston, Massachusetts
- +2 more
Jan 16, 2018
Myeloma Trial in Houston (biological, drug, procedure)
Terminated
- Myeloma
- KLH Vaccine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 29, 2018
Prostatic Tumors Trial in Stanford (Mitoxantrone, GM-CSF)
Terminated
- Prostatic Neoplasms
- Mitoxantrone
- GM-CSF
-
Stanford, CaliforniaStanford University School of Medicine
Oct 23, 2017